|
ZNF100 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.893400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.635000E-01 |
| Normal-vs-Stage2 |
7.088400E-01 |
| Normal-vs-Stage3 |
9.694200E-02 |
| Normal-vs-Stage4 |
8.919900E-02 |
| Stage1-vs-Stage2 |
7.730400E-01 |
| Stage1-vs-Stage3 |
5.199800E-02 |
| Stage1-vs-Stage4 |
5.192500E-02 |
| Stage2-vs-Stage3 |
4.657400E-01 |
| Stage2-vs-Stage4 |
4.081800E-01 |
| Stage3-vs-Stage4 |
8.399200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.434000E-01 |
| Normal-vs-AfricanAmerican |
1.412410E-01 |
| Normal-vs-Asian |
9.086600E-01 |
| Caucasian-vs-AfricanAmerican |
3.170600E-01 |
| Caucasian-vs-Asian |
8.719000E-01 |
| AfricanAmerican-vs-Asian |
5.627600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.555400E-01 |
| Normal-vs-Female |
5.130200E-01 |
| Male-vs-Female |
7.980000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.315000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.338200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.402400E-02 |
| Normal-vs-Age(81-100Yrs) |
5.359800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.117800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.144500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.724500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.264000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.797640E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.880600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.026800E-01 |
| Normal-vs-Grade 2 |
6.998800E-01 |
| Normal-vs-Grade 3 |
5.640400E-02 |
| Normal-vs-Grade 4 |
3.075500E-02 |
| Grade 1-vs-Grade 2 |
9.481200E-01 |
| Grade 1-vs-Grade 3 |
1.511350E-01 |
| Grade 1-vs-Grade 4 |
1.210790E-01 |
| Grade 2-vs-Grade 3 |
2.917700E-03 |
| Grade 2-vs-Grade 4 |
3.977700E-03 |
| Grade 3-vs-Grade 4 |
3.909000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.268200E-01 |
| Normal-vs-ccB subtype |
3.457800E-01 |
| ccA subtype-vs-ccB subtype |
1.583820E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.713000E-01 |
| Normal-vs-N1 |
2.989000E-01 |
| N0-vs-N1 |
4.469800E-01 |
|
|
